1Storb R , Blume KG, O' Donnell MR et al . Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantation:the experience in four centers. Biol Blood Marrow Transplantation, 2001,7 ( 1 ) : 39
2达万明．血液病学(中华医学会继续教育医学教育教材)．北京：中华医学电子音像出版社．2005．1
3Beverly JL, Franklin OS, Patrica AD et al . Outcomes in CCG - 2961, a Children' s Cancer Group Phase Ⅲ Trial for Untreated Acute Myeloid Leukemia (AML). Blood (ASH .Annual Meeting Abstracts 169) ,2005,106(11) :53
4Karen Ballen, Kathleen A, Sobocinski et al . Outcome of Bone Marrow Transplantation for Myelofibrosis. Blood ( ASH Annual Meeting Abstracts 170), 2005,106( 11 ) : 53
5Masahiro Tsuchida, Hiroshi Sao, Hisashi Sakamaki et al .Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. Blood (ASH Annual Meeting Abstracts 442), 2005,106( 11 ) : 134
6Martha LA, Amelia Langston, Sagar Lonial. Decreased Incidence of Relapse in Patients with Acute Leukemia Transplanted from Matched Unrelated Donors: Induction of GVL.Blood ( ASH Annual Meeting Abstracts 2016 ), 2005, 106(11):570
7Rubinstein P, Carrier C, Scaradavou A et al . Outcomes among 562 recipients of placental - blood transplants from unrelated donors. N Engl J Med, 1998,339:1565
8Davey S, Armitage S, Rocha Vet al . The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol,2004, 125 : 358
2Thomas ED, Strob R, Clift RA, et al. Bone-marrow transplantation(second of the two part). N Engl J Med, 1975, 292: 895-902.
3Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconis: anemia by means of umbilical cord blood from an HCA. Identical sibling. N Engl J Med,1989,321:1174-1878.
4Gluckman E,Rocha V,Boyer Chammard A,et al.Outcome of cord—blood tranplantation from related and unrelated donors.N Engl J Med,1997,337:373—381.
5Rubinstein P,Carrrier C,Scardadavoll A,et al.Outcomes among 562 recipients of plancental-blood transplants from unrelated donors. N Engl J Med,1998,339:1565—1577.
6Laughlin M,Barker J,Bambach B,et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.N Engl J Med,2001,344:1815—1822.
7Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation[J]. Blood, 2001, 98: 3192-3204
8Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter[J]? Blood, 2001, 98: 2900-2908
9Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells[J]. Blood, 2001, 98: 3186-
10Przerpiorka KM, Weisdorf D, Martin P, et al. 1994 consensus conference on aGVHD grading[J]. Bone Marrow Transplant, 1995, 15: 825-828
